News & Analysis as of

Office of the Inspector General › Private Equity › Investors

Morgan Lewis - As Prescribed

Navigating Key Challenges in M&A Deals in the Rare Disease Sector

Morgan Lewis - As Prescribed on

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed and Health Law Scan, focusing on issues impacting the rare disease community. The value of merger and...more

Orrick, Herrington & Sutcliffe LLP

Health Care Compliance: New Federal Guidance Seeks a Modernized Approach and Shows OIG’s Specific Interest in Private Equity and...

Orrick, Herrington & Sutcliffe LLP on

The Department of Health and Human Services Office of Inspector General (HHS-OIG) has issued new general compliance program guidance, marking the first time the agency has released this type of “reference guide for the health...more

Akin Gump Strauss Hauer & Feld LLP

Life Sciences Due Diligence: A Reference Guide for Your Life Sciences Corporate Transactions

Akin Gump Strauss Hauer & Feld LLP on

• Life sciences companies are subject to rapidly changing regulatory obligations, government enforcement, and increasing public scrutiny. • Conducting effective legal and regulatory due diligence can mean uncovering risks...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide